Inventor · disambiguated record
Francis P. Kuhajda
Also filed as: KUHAJDA FRANCIS · KUHAJDA FRANCIS P · KUHAJDA FRANCIS PAUL
11 granted patents·16 pending applications·477 citations·filing 1994–2011
92Inventor score
Files withUNIV JOHNS HOPKINS8UNIV JOHNS HOPKINS MED7KUHAJDA FRANCIS P3FASGEN INC2FASGEN DIAGNOSTICS LLC1
Top patents by PatentIndex Score
27 records- 0196US5759837AChemotherapy for cancer by inhibiting the fatty acid biosynthetic pathwayUNIV JOHNS HOPKINS·Filed 1994·Granted Jun 2, 1998·208 cites·40 claims
- 0284US5981575AInhibition of fatty acid synthase as a means to reduce adipocyte massUNIV JOHNS HOPKINS·Filed 1996·Granted Nov 9, 1999·68 cites·19 claims
- 0384US5614551AInhibitors of fatty acid synthesis as antimicrobial agentsUNIV JOHNS HOPKINS·Filed 1994·Granted Mar 25, 1997·90 cites·14 claims
- 0476US7459481B2Stimulation of CPT-1 as a means to reduce weightUNIV JOHNS HOPKINS MED·Filed 2006·Granted Dec 2, 2008·6 cites·3 claims
- 0574US5759791ACancer related antigenUNIV JOHNS HOPKINS·Filed 1994·Granted Jun 2, 1998·29 cites·18 claims
- 0672US5665874ACancer related antigenUNIV JOHNS HOPKINS·Filed 1995·Granted Sep 9, 1997·36 cites·10 claims
- 0772US2010022639A1Methods of Inducing Weight LossUNIV JOHNS HOPKINS MED·Filed 2009·Application pending·0 cites
- 0870US7649012B2Compounds, pharmaceutical compositions containing same, and methods of use for sameFASGEN INC·Filed 2003·Granted Jan 19, 2010·13 cites·11 claims
- 0960US2007197638A1Weight loss induced by reduction in neuropeptide levelUNIV JOHNS HOPKINS MED·Filed 2007·Application pending·0 cites
- 1055US6713654B1Antimicrobial compoundsUNIV JOHNS HOPKINS MED·Filed 1998·Granted Mar 30, 2004·5 cites·22 claims
- 1155US2009124684A1Stimulation Of CPT-1 As A Means To Reduce WeightUNIV JOHNS HOPKINS MED·Filed 2008·Application pending·0 cites
- 1254US7385086B2Antimicrobial compoundsUNIV JOHNS HOPKINS MED·Filed 2004·Granted Jun 10, 2008·1 cites·11 claims
- 1354US2004157918A1Weight loss induced by reduction in neuropeptide y levelFiled 2001·Application pending·0 cites
- 1453US5872217AAntibodies which specifically bind a cancer related antigenUNIV JOHNS HOPKINS·Filed 1995·Granted Feb 16, 1999·12 cites·6 claims
- 1552US2007142456A1Method for inhibiting cancer development by fatty acid synthase inhibitorsUNIV JOHNS HOPKINS·Filed 2003·Application pending·0 cites
- 1648US5864011ACancer related antigenUNIV JOHNS HOPKINS·Filed 1995·Granted Jan 26, 1999·9 cites·5 claims
- 1748US2005106217A1Stimulation of CPT-1 as a means to reduce weightJOHNS HOPKINS UNIVERSITY LICEN·Filed 2004·Application pending·0 cites
- 1847US2010168176A1Novel compounds, pharmaceutical compositions containing same, and methods of use for sameFASGEN LLC·Filed 2007·Application pending·0 cites
- 1945US2005143467A1Stimulation of cpt-1 as a means to reduce weightUNIV JOHNS HOPKINS MED·Filed 2003·Application pending·0 cites
- 2044US2010168218A1Method of reducing food intakeKUHAJDA FRANCIS P·Filed 2006·Application pending·0 cites
- 2142US2009162870A1Fatty acid synthase in liver diseaseFASGEN DIAGNOSTICS LLC·Filed 2008·Application pending·0 cites
- 2242US2002173447A1Cytostatic effects of fatty acid synthase inhibitionFiled 2002·Application pending·0 cites
- 2340US2010029752A1Novel compounds, pharmaceutical compositions containing same, and methods of use for sameKUHAJDA FRANCIS P·Filed 2006·Application pending·0 cites
- 2440US2010029761A1Novel compounds, pharmaceutical compositions containing same, and methods of use for sameKUHAJDA FRANCIS P·Filed 2006·Application pending·0 cites
- 2537US2012083471A1Novel Compounds, Pharmaceutical Compositions Containing Same, Methods of Use for Same, and Methods for Preparing SameTOWNSEND CRAIG A·Filed 2011·Application pending·0 cites
- 2635US2002187534A1Treating cancer by increasing intracellular malonyl CoA levelsFiled 2002·Application pending·0 cites
- 2732US2010120901A1Novel compounds, pharmaceutical compositions containing same, and methods of use for sameFASGEN INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Francis P. Kuhajda files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →